Skip to main content

Table 4 Complications in death cases between MSC group and non-MSC group

From: Mesenchymal stromal cell treatment improves outcomes in children with pneumonia post-hematopoietic stem cell transplantation: a retrospective cohort study

 

MSC

Non-MSC

p value

n (%)

n (%)

Severe pneumonia

4 (100)

10 (100)

0.758

 Respiratory failure

4 (100)

10 (100)

 

 GVHD

0 (0)

2 (20)

 

 Organ failure

1 (25)

2 (20)

 

 Septicemia

1 (25)

1 (10)

 

 Secondary diabetes

1 (25)

0 (0)

 

 Shock

0 (0)

3 (30)

 

 Mediastinal emphysema

0 (0)

2(20)

 

 Non-pulmonary inflammation

1 (25)

2 ( 20)

Â